<DOC>
	<DOCNO>NCT02095665</DOCNO>
	<brief_summary>Ureteric stent use often follow ureteroscopy prevention obstruction edema stone fragment . They often associate pain , void often , need urinate quickly find blood urine call `` low urinary tract symptom '' LUTS short . There randomized study show efficacy α-blockers tamsulosin relieve `` stent symptom '' ( pain LUTS ) . There emerge limit evidence show antimuscarinic medication , use treat overactive bladder ( OAB ) efficacy decrease stent symptom . Mirabegron beta-agonist use decrease OAB symptom . Mirabegron function mediate relaxation detrusor muscle useful treat OAB symptom . Conventional antimuscarinic medication often bothersome side effect like dry mouth , constipation , blur vision cognitive impairment . This may limit use population . Mirabegron well-tolerated good safety profile therefore may useful treat stent symptom without bothersome side effect commonly see antimuscarinic medication . . The investigator hypothesize mirabegron effective decrease ureteral stent relate LUTS pain .</brief_summary>
	<brief_title>Ureteral Stent-related Pain Mirabegron ( SPAM ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<mesh_term>Narcotics</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Age ≥18 year First presentation ureteroscopy particular stone Planned insertion double J ureteral stent Planned ureteral stenting ≥5 day Followup conduct Queen Elizabeth II Health Sciences Centre Bilateral ureteral stent insert Stent already situ prior ureteroscopy Patients congenital renal abnormality ( ie : horseshoe kidney , ectopic kidney , etc ) Patients urinary diversion Patients history interstitial cystitis/painful bladder syndrome , chronic prostatitis , neurogenic bladder Indwelling foley catheter Active urinary tract infection Patients currently take antimuscarinics , mirabegron , αblockers Patients contraindication receive either mirabegron tamsulosin ( ie : urinary retention , endstage renal disease , orthostatic hypotension , uncontrolled hypertension , know QT prolongation , severe aortic regurgitation ) , significant cognitive impairment , pregnancy , active urinary tract infection Planned upcoming elective cataract surgery Suspected confirm ureteral perforation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ureteric stent</keyword>
	<keyword>LUTS</keyword>
	<keyword>low urinary tract symptom</keyword>
</DOC>